Abramson Cancer Center of the Univ. of Pennsylvania /ID# 1128-0402 — Philadelphia, Pennsylvania

Abramson Cancer Center of the Univ. of Pennsylvania /ID# 1128-0402 is a clinical research site located in Philadelphia, Pennsylvania, United States 19104.

Crixeo Health Trust Score: 57/100 (POOR). This profile has not yet been claimed by the site owner.

Abramson Cancer Center of the Univ. of Pennsylvania /ID# 1128-0402 has participated in 1 clinical trials.

Therapeutic areas: Metastatic Renal Cell Carcinoma, Advanced Urothelial Carcinoma, Advanced Gastric Adenocarcinoma.

Sponsors: Pharmacyclics LLC..

Sponsor Feasibility Report

Trust Score: 57/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Abramson Cancer Center of the Univ. of Pennsylvania /ID# 1128-0402?

Abramson Cancer Center of the Univ. of Pennsylvania /ID# 1128-0402 has a Crixeo Trust Score of 57/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Abramson Cancer Center of the Univ. of Pennsylvania /ID# 1128-0402 conducted?

Abramson Cancer Center of the Univ. of Pennsylvania /ID# 1128-0402 has 1 clinical trials on record. Their work covers Metastatic Renal Cell Carcinoma, Advanced Urothelial Carcinoma, Advanced Gastric Adenocarcinoma.

Is Abramson Cancer Center of the Univ. of Pennsylvania /ID# 1128-0402 accredited by Crixeo Health?

Abramson Cancer Center of the Univ. of Pennsylvania /ID# 1128-0402 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Abramson Cancer Center of the Univ. of Pennsylvania /ID# 1128-0402?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.